Safety study of HRS9531 injection for teen obesity
Part of Hormones & metabolism clinical trials.
This study tests whether a new injectable medication called HRS9531 is safe and well-tolerated in teenagers aged 12–17 with obesity. Researchers will monitor how your body handles the medication and whether it affects your weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old
- You meet obesity criteria based on BMI for your age group
- You've tried diet and exercise for at least 12 weeks with little weight change (less than 5% BMI decrease)
- You don't have diabetes, uncontrolled high blood pressure, or significant mental health conditions
- You haven't had major surgery, acute infection, or significant blood loss in the past month
- You're not taking medications that significantly affect weight and haven't had surgery planned during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.
This study tests an injectable medication called HRS9531 for people with obesity and obstructive sleep apnea. The goal is to see if it can help reduce breathing pauses during sleep and promote weight loss.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
Hear when a new Overweight and Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.